1) Evolution? I'm referring to the age related decline in TT levels as a protective mechanism rather than an evolutionary response that often requires hundred if not thousands of years.
The fact is as, I eluded to earlier, MANY of those now on TRT don't NEED it, but rather are following the media and big blog hype correcting a "low TT" level can cure mankind ills from A-Z. And the risks, although small and difficult to quantify, are probably the equivalent of youthful maleness, IMO
2) I suspect Nandrolone has been studied more than any other AAS except one Testosterone, and the differences are indeed striking in many respects
Moreover Nandrolone poses some distinct differences in part bc of its relatively high lipid solubility, generation of at least three active metabolites, hepatic conjugation,
and high A;A ratio. And like many drug specific metabolites, how and where they are processed physiologically is often responsible for the toxicities observed.
And bc of these and other metabolic differences, much like antibiotics have variable therapeutic and "toxic" ranges, I believe it's important to avoid charicterizing AAS as being more of the same until such data avails itself.
JIM
The fact is as, I eluded to earlier, MANY of those now on TRT don't NEED it, but rather are following the media and big blog hype correcting a "low TT" level can cure mankind ills from A-Z. And the risks, although small and difficult to quantify, are probably the equivalent of youthful maleness, IMO
2) I suspect Nandrolone has been studied more than any other AAS except one Testosterone, and the differences are indeed striking in many respects
Moreover Nandrolone poses some distinct differences in part bc of its relatively high lipid solubility, generation of at least three active metabolites, hepatic conjugation,
and high A;A ratio. And like many drug specific metabolites, how and where they are processed physiologically is often responsible for the toxicities observed.
And bc of these and other metabolic differences, much like antibiotics have variable therapeutic and "toxic" ranges, I believe it's important to avoid charicterizing AAS as being more of the same until such data avails itself.
JIM